Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations are Transforming Patient Care

0.50 hr(s) | CME

Specialty: Chronic Lymphocytic Leukemia (CLL)

Therapeutic Area(s): Chronic Lympoblastic Leukemia (CLL) , Hematology, Malignant , Oncology

Release Date: September 7, 2021

Expiration Date: September 6, 2022

Location: Internet Activity Enduring

Modern management of chronic lymphocytic leukemia (CLL) has been transformed by innovative therapeutics, including BTK and BCL-2 inhibitors, in a range of patient populations and treatment settings—but what is the next step? In this activity, an expert clinician addresses that question and reviews evidence on emerging targeted options and novel combination strategies likely to affect patient care.

Access this activity